Business
Palvella Therapeutics Launches "BEYOND mLM" Disease Awareness Campaign for Microcystic Lymphatic Malformations in Collaboration with Leading Lymphatic, Vascular, and Dermatology Nonprofit Organizations
BEYONDmLM.com campaign designed to educate, engage, and empower patients, caregivers, and healthcare professionals Campaign developed and launched in close
About this update from Palvella Therapeutics, Inc.
[{"type":"text","content":"BEYONDmLM.com campaign designed to educate, engage, and empower patients, caregivers, and healthcare professionals Campaign developed and launched in close collaboration with leading nonprofit organizations, including the Consortium of iNvestigators of Vascular AnomalieS (CaNVAS), Lymphangiomatosis & Gorham’s Disease Alliance (LGDA), the Lymphatic Education & Research Network (LE&RN), Pediatric Dermatology Research Alliance (PeDRA), and VAccess.org Microcystic lymphatic malformations (microcystic LMs) are a rare, chronically debilitating and lifelong disease affecting an estimated more than 30,000 diagnosed patients in the United States, with no FDA-approved therapies available WAYNE, Pa., March 10, 2026 (GLOBE NEWSWIRE) -- (Nasdaq: PVLA) Palvella Therapeutics, Inc. (Palvella or “the Company”), a clinical-stage biopharmaceutical company focused on developing and commercializing novel therapies to treat patients suffering from serious, rare skin diseases and vascular malformations for which there are no U.S. Food and Drug Administration (FDA)-approved therapies, today announced the launch of \"BEYOND mLM,\" a new disease state awareness campaign and website, BEYONDmLM.com, designed to educate, engage, and empower patients, caregivers, and healthcare professionals about microcystic lymphatic malformations (microcystic LMs). Microcystic LMs are a rare, chronically debilitating disease characterized by malformed lymphatic vessels that can protrude through the skin and persistently leak lymph fluid (lymphorrhea) and bleed, often leading to recurrent serious infections resulting in hospitalization. BEYONDmLM.com is an educational website created to help patients, caregivers, and healthcare professionals better understand its underlying biology and full functional and psychosocial impact. The multi-stakeholder campaign is being developed in partnership with leading nonprofit organizations and experts across the dermatology and lymphatic malformation communities, including: The Consortium of iNvestigators of Vascular AnomalieS (CaNVAS), a multi-institutional research consortium founded by a group of pediatric hematologist-oncologists and patient advocacy groups to address the rare nature of vascular anomalies.Lymphangiomatosis & Gorham’s Disease Alliance (LGDA), a nonprofit organization dedicated to improving the lives of patients affec...